This list is an analysis based on recent market events. It's not an investment recommendation.
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
FAQs
What is ADARx Pharmaceuticals stock price today?▼
The current price of ADRX is $17.00 USD — it has decreased by -4.76% in the past 24 hours. Watch ADARx Pharmaceuticals stock price performance more closely on the chart.
What is ADARx Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ADARx Pharmaceuticals stocks are traded under the ticker ADRX.
What is ADARx Pharmaceuticals market cap?▼
Today ADARx Pharmaceuticals has the market capitalization of 1.82B
What were ADARx Pharmaceuticals earnings last quarter?▼
ADRX earnings for the last quarter are -2.27 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is ADARx Pharmaceuticals located?▼
ADARx Pharmaceuticals operates in the Manufacturing sector.
When did ADARx Pharmaceuticals complete a stock split?▼
The last stock split for ADARx Pharmaceuticals was on April 4, 2000 with a ratio of 2:1.
Where is ADARx Pharmaceuticals headquartered?▼
ADARx Pharmaceuticals is headquartered in San Diego, United States.